Related Experiment Video
Updated: Jul 15, 2026

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
Proximal ventricular shunt catheter occlusion model
David Qi1, Anup Patel2, Robert Dunwoody2
1Department of Neurosurgery, University of Illinois College of Medicine at Peoria, Peoria, IL, USA. mq3@uic.edu.
Insights
Researchers developed a novel in vitro model for proximal ventricular shunt catheter occlusion. This model consistently replicates occlusion within 5 minutes, aiding the study of shunt malfunction.
Area of Science:
- Biomedical Engineering
- Neurosurgery
- Pathology
Background:
- Proximal ventricular shunt catheter occlusion is a frequent cause of shunt malfunction.
- Existing in vivo and in vitro models are inconsistent for studying shunt occlusion.
- This limits research into improved shunt designs and treatments.
Purpose of the Study:
- To develop and calibrate a consistent in vitro model for proximal ventricular shunt catheter occlusion.
- To mimic choroid plexus-induced occlusion using biological agents.
- To establish a reliable method for studying shunt failure mechanisms.
Main Methods:
- An in vitro model was created using standard proximal ventricular catheters.
- Biological occluding agents (chalaza, vitelline membranes from avian eggs) were employed.
- Occlusion was achieved using a 100 cmH2O hydrostatic pressure differential.
- Successful occlusion was defined as >90% reduction in flow rate.
- Histopathological analysis of occluded catheters was performed.
Main Results:
- Consistent catheter occlusion was achieved within 24 hours using chalaza, vitelline membrane, or combined treatments.
- Repeat trials showed successful occlusion within 5 minutes using only vitelline membrane.
- Histopathology revealed vitelline membrane as extraembryonic ectoderm and chalaza as mucin protein strands.
Conclusions:
- A reproducible in vitro model for proximal ventricular shunt catheter occlusion was successfully developed and calibrated.
- The model achieves consistent occlusion within 5 minutes.
- This model can facilitate rapid testing of occlusion-resistant shunt designs and de-obstruction techniques.
Purpose:
Proximal ventricular shunt catheter occlusion remains a problematic cause of shunt malfunction, and there is no consistent in vivo or in vitro model to help clinicians and researchers study this phenomenon.
Methods:
An in vitro model utilizing standard proximal ventricular catheter and biological occluding agents mimicking choroid plexus was designed, constructed, and calibrated to occlude consistently within a specified timeframe. Hydrostatic pressure differential of 100 cmH2O was used as a driving force to generate flow through the catheter. Chalaza and vitelline membranes were harvested from avian eggs and used as occluding agents. Successful occlusion was defined as a greater than 90% reduction in volumetric flow rate through distal outlet. Histological sections of occluded catheters were performed and interpreted by a neuropathologist.
Results:
Initial trials demonstrated successful standard catheter occlusion within 24 h using chalaza, vitelline membrane, and combination treatments. Repeat trials demonstrated consistency in successful occlusion within 5 min utilizing only vitelline membrane treatment. Histopathology demonstrated the vitelline membrane to consist of a thin, superficial layer of extraembryonic ectoderm; the chalaza was observed to consist of strands of mucin protein.
Conclusions:
An in vitro model of proximal ventricular shunt catheter occlusion was developed and calibrated for successful occlusion within 5 min. Future studies may utilize this model to rapidly test occlusion-resistant shunt designs and de-obstruction techniques.
Related Concept Videos
Shunt Admittances
To model this effect, the method of images is employed. This method involves replacing the Earth with an image conductor that mirrors the original...
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management

